Skip to main content
Equibles
ILMN logo

ILMN · Illumina, Inc. · Investor Relations

Track ILMN — free

Use ILMN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ILMN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$273.68 +1.68 (+0.62%) At close · Sep 30
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$40.77B
Shares
151.00M
Volume · Sep 30 2.94M Avg daily vol (3M) 2.6M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-07-16 Illumina expands Billion Cell Atlas program with new AI drug developers
2026-07-09 Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
2026-07-09 Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer
2026-06-23 Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors
2026-06-08 Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution
2026-05-28 Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research
2026-05-28 Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research
2026-05-21 David P. King elected to Illumina's Board of Directors
2026-05-19 Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact
2026-04-30 Illumina Reports Financial Results for First Quarter of Fiscal Year 2026
2026-04-16 DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows
2026-04-14 Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease
2026-04-09 Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026
2026-04-02 Illumina Announces Changes to Board of Directors

Past events

Date Event Type
2026-07-30 Q2 2026 Illumina, Inc. Earnings Conference Call Earnings call
2026-04-30 Q1 2026 Illumina, Inc. Earnings Conference Call Earnings call
2026-03-03 TD Cowen 46th Annual Health Care Conference Conference
2026-02-05 Q4 and Fiscal Year 2025 Illumina, Inc. Earnings Conference Call Earnings call
2026-01-13 44th Annual J.P. Morgan Healthcare Conference Conference
2025-11-19 Wolfe Research Healthcare Conference 2025 Conference
2025-10-30 Q3 2025 Illumina, Inc. Earnings Conference Call Earnings call
2025-10-08 Illumina Stewardship-Focused Update (October 2025) Event
2025-07-31 Q2 2025 Illumina, Inc. Earnings Conference Call Earnings call
2025-06-23 Illumina to Acquire Somalogic Event
2025-05-28 41st Annual Bernstein Strategic Decisions Conference Conference
2025-05-08 Q1 2025 Illumina, Inc. Earnings Conference Call Earnings call
2025-02-25 Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference Conference
2025-02-06 Q4 and Fiscal Year 2024 Illumina, Inc. Earnings Conference Call Earnings call
2025-01-14 43rd Annual J.P. Morgan Healthcare Conference Conference
2024-12-03 7th Annual Evercore HealthCONx Conference Conference
2024-11-20 Wolfe Research 2024 Healthcare Conference Conference
2024-11-04 Q3 2024 Illumina, Inc. Earnings Conference Call Earnings call
2024-10-22 Illumina Stewardship-Focused Update (October 2024) Event
2024-08-13 Illumina Strategy Update Event
2024-08-06 Q2 2024 Illumina, Inc. Earnings Conference Call Earnings call
2024-06-24 GRAIL Spin-off Event
2024-05-29 Bernstein 40th Annual Strategic Decisions Conference Conference
2024-05-14 RBC 2024 Global Healthcare Conference Conference
2024-05-13 GRAIL Capital Markets Day 2024 Event

Source: https://investor.illumina.com/

Key facts CIK 1110803 CUSIP 452327109 13F (30d) 21 filings 16 filers Visit website Investor relations